Emmessar Biotech & Nutrition Ltd Intrinsic Value
EMMESSA · Chemicals · Current price ₹24.55
Is Emmessar Biotech & Nutrition Ltd undervalued?
DocStoX estimates the fair value of Emmessar Biotech & Nutrition Ltd at ₹30 per share, versus the current market price of ₹25. That puts the stock about +22.0% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹14), Relative P/E (₹68), Graham floor (₹23). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹14 (bear) to ₹30 (base) to ₹68 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹25 versus an intrinsic value of ₹30, Emmessar Biotech & Nutrition Ltd currently offers +22.0% of margin.
More on Emmessar Biotech & Nutrition Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.